Q J Med 2000; 93: 323-333
© 2000 Association of Physicians
Review |
The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia
From the Departments of Endocrinology and Medicine, Cork University Hospital and University College Cork, Cork, Ireland
Organisms survive by maintaining equilibrium with their environment. The stress system is critical to this homeostasis. Glucocorticoids modulate the stress response at a molecular level by altering gene expression, transcription, and translation, among other pathways. The effect is the inhibition of the functions of inflammatory cells, predominantly mediated through inhibition of cytokines, such as IL-1, IL-6, and TNF-
. The central effectors of the stress response are the corticotrophin-releasing hormone (CRH) and locus coeruleus-norepinephrine (LC-NE)/sympathetic systems. The CRH system activates the stress response and is subject to modulation by cytokines, hormones, and neurotransmitters. Glucocorticoids also modulate the growth, reproductive and thyroid axes. Abnormalities of stress system activation have been shown in inflammatory diseases such as rheumatoid arthritis, as well as behavioural syndromes such as melancholic depression. These disorders are comparable to those seen in rats whose CRH system is genetically abnormal. Thus, the stress response is central to resistance to inflammatory and behavioural syndromes. In this review, we describe the response to stress at molecular, cellular, neuroendocrine and behavioural levels, and discuss the disease processes that result from a dysregulation of this response, as well as recent developments in their treatment.
Address correspondence to Dr T.M. O'Connor, Department of Respiratory Medicine, Cork University Hospital, Wilton, Cork, Ireland. e-mail: terryoconnor{at}eircom.net
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. MASTORAKOS and I. ILIAS Interleukin-6: A Cytokine and/or a Major Modulator of the Response to Somatic Stress Ann. N.Y. Acad. Sci., November 1, 2006; 1088(1): 373 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Lee, R. C. Webb, and M. W. Brands Sympathetic and angiotensin-dependent hypertension during cage-switch stress in mice Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1394 - R1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Aller, J. L. Arias, M. P. Nava, and J. Arias Posttraumatic Inflammation Is a Complex Response Based on the Pathological Expression of the Nervous, Immune, and Endocrine Functional Systems Experimental Biology and Medicine, February 1, 2004; 229(2): 170 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Beishuizen and L. G. Thijs Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis Innate Immunity, February 1, 2003; 9(1): 3 - 24. [Abstract] [PDF] |
||||
![]() |
J. Bienenstock Stress and Asthma: The Plot Thickens Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1034 - 1035. [Full Text] [PDF] |
||||
![]() |
C. Bousquet, V. Chesnokova, A. Kariagina, A. Ferrand, and S. Melmed cAMP Neuropeptide Agonists Induce Pituitary Suppressor of Cytokine Signaling-3: Novel Negative Feedback Mechanism for Corticotroph Cytokine Action Mol. Endocrinol., November 1, 2001; 15(11): 1880 - 1890. [Abstract] [Full Text] [PDF] |
||||





